Wednesday, February 21, 2018

Significant Mortality Benefit Seen With Sustained HCV Virologic Response With DAAs

Significant Mortality Benefit Seen With Sustained HCV Virologic Response With DAAs
Hannah Dellabella
For patients infected with hepatitis C virus (HCV) without advanced liver disease, achieving sustained virologic response with direct-acting antivirals (DAAs) is associated with decreased mortality, according to results published in Hepatology.

Posted by at
File Under

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)